
High zzso is a well-known risk factor for the development and recurrence of several solid zzso including zzso zzso is associated with increased levels of vascular zzso growth factor zzso zzso is the main targeted therapy for zzso zzso zzso by blocking the zzso zzso zzso zzso zzso in obese patients might provoke resistance to zzso zzso We evaluated the efficacy of zzso on zzso among zzso patients through zzso them according to their zzso Patients with zzso who had been treated with zzso combination chemotherapy with zzso were included in the zzso Patients were assigned according to their zzso before initiation of therapy zzso zzso zzso zzso zzso group B: zzso zzso 25 zzso zzso analysis was performed to evaluate the risk of zzso zzso Between April 2007 and June 2011, 80 patients were treated with chemotherapy and zzso as zzso therapy zzso zzso 37 for group A, zzso zzso 43 for group zzso zzso in zzso % of the patients in group A zzso zzso zzso and zzso % of the patients in group B zzso zzso zzso progressed during a median zzso zzso zzso zzso The median zzso was zzso months in the group A and 6 months in the group B zzso zzso zzso In a zzso analysis, high zzso zzso zzso was associated with significantly shorter zzso zzso zzso zzso zzso zzso High zzso among zzso patients treated with zzso is associated with shorter zzso Further study in larger databases is warranted for confirming the negative zzso effect of obesity during treatment with zzso zzso 

